Invention Grant
- Patent Title: Antisense oligonucleotides for the treatment of leber congenital amaurosis
-
Application No.: US15963229Application Date: 2018-04-26
-
Publication No.: US10167470B2Publication Date: 2019-01-01
- Inventor: Robert Wilhelmus Johanna Collin , Franciscus Peter Maria Cremers , Antonia Ingrid Den Hollander
- Applicant: STICHTING KATHOLIEKE UNIVERSITEIT
- Applicant Address: NL Nijmegen
- Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
- Current Assignee: STICHTING KATHOLIEKE UNIVERSITEIT
- Current Assignee Address: NL Nijmegen
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: NL2007351 20110905
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
The present invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Leber congenital amaurosis.
Public/Granted literature
- US20180305692A1 ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS Public/Granted day:2018-10-25
Information query
IPC分类:
